Newsletter Subject

When Alzheimer's disease is at work and home

From

wbur.org

Email Address

newsletters@wbur.org

Sent On

Tue, Dec 6, 2022 08:02 PM

Email Preheader Text

Also: Are we seeing a post-Thanksgiving COVID bump — or a spike? December 6, 2022

Also: Are we seeing a post-Thanksgiving COVID bump — or a spike? [View in browser](    [❤️]( December 6, 2022 Hi CommonHealth reader, Last week was a big one in the world of Alzheimer's disease research, as scientists [unveiled the much-anticipated results of their trial]( on the latest experimental drug. Dorene Rentz was there to hear about it. Rentz lives and works with Alzheimer's about as closely as anyone. Not only is she the co-director of the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital, her husband has the disease. After last week's big news, I wanted to speak with her about what the findings showed, how she became interested in Alzheimer's research, and what it's like living with a person who has Alzheimer's disease. Here are some highlights from our conversation. What to make of the new drug Rentz was in the room at an Alzheimer's conference in San Francisco when researchers presented their findings on the latest drug, lecanemab, which is aimed at stopping the progression of Alzheimer’s disease. The study showed there was a bit of success in slowing cognitive declines, but there were also real risks, like swelling and bleeding in the brain, and even death. “The reactions were mixed,” Rentz said of the response to the findings at the conference. “Some people were very excited about it, calling it historic. They love the transparency of the trial. Other people were warning, ‘but this is only a modest effect.’ ” “It's not a cure for Alzheimer's disease, but it's really a step forward,” she added. “It's really one of the first positive trials for a disease-modifying agent in Alzheimer's disease.” On studying this disease Rentz was working on her doctoral degree when she saw her first patient with Alzheimer’s disease. She decided to write her dissertation on the condition because of its unique nature. “[This was] at a time when Alzheimer's disease was not a household name,” she recalled. “What interested me about it was the fact that Alzheimer's disease robs people of their personality, their memories, and who they are, their sense of self. And I never thought a disease could do that.” After practicing as a neuropsychologist and studying memory, Rentz returned to her focus on Alziehmer’s disease. She’s now been working in this field for more than 30 years. On living alongside this disease Roughly two decades ago, Rentz transformed her home office into a bedroom, and her mother-in-law moved in. She’d just been diagnosed with Alzheimer’s disease, and she lived with Rentz and her family for a number of years up until her death. “We watched her deteriorate because there wasn't anything you could really do for the disease at that particular time,” Rentz said, adding that her mother-in-law’s three sisters also developed Alzheimer’s. Despite knowing that the disease runs in families — and intimately knowing the symptoms — Rentz said it took her a couple of years to acknowledge that her husband was showing signs of Alzheimer’s disease, too. This was about five years ago. She then worked quickly to get him into a study aimed at preventing the progression of the disease. She says she feels lucky that he can still drive and go to the store and cook. “He has very little awareness of his memory problems,” she said. “One of the beauties of the disease is that it robs people, sometimes, of their self-awareness. And so he isn't living moment-to-moment with the fact that he forgets. It only comes to him periodically.” Still, Rentz said, it’s with their kids in mind that she keeps working long hours. “We don't want them to have to go through this, or our grandkids to have to take care of their parents,” she said. “Am I optimistic that we'll get there in time? I hope so.” P.S.— If there's still room in your holiday schedule, WBUR CitySpace has a few upcoming events that readers of this newsletter may be interested in. As part of a mini-series on health and longevity starting tomorrow, Meghna Chakrabarti is hosting deep-dive discussions with Dan Buettner ([on the places with the highest concentration of centenarians]( and David Sinclair ([on why aging might be reversible](. Both in-person and virtual tickets are available. Gabrielle Emanuel Health reporter [Follow]( Support the news  This Week's Must Reads [Bump or spike? COVID in wastewater has experts unsurprised but wary]( As people gathered with loved ones over the holiday weekend, data suggests the virus had an opportunity to spread. But so far hospitals have seen only modest increases in patients hospitalized or in intensive care units with COVID. [Read more.]( [Bump or spike? COVID in wastewater has experts unsurprised but wary]( As people gathered with loved ones over the holiday weekend, data suggests the virus had an opportunity to spread. But so far hospitals have seen only modest increases in patients hospitalized or in intensive care units with COVID. [Read more.]( [For patients with sickle cell disease, fertility care is about reproductive justice]( The disease, which predominantly affects patients of color, can damage the body in ways that can make it difficult to have a child. But patients don't always have access to fertility care. [Read more.]( [For patients with sickle cell disease, fertility care is about reproductive justice]( The disease, which predominantly affects patients of color, can damage the body in ways that can make it difficult to have a child. But patients don't always have access to fertility care. [Read more.]( [Thanks to the 'tripledemic,' it can be hard to find kids' fever-reducing medicines]( Makers of products like Children's Tylenol say they're trying to keep up with big demand as RSV, flu, and COVID spread. But medical experts note that kids' fevers don't always call for medicine. [Read more.]( [Thanks to the 'tripledemic,' it can be hard to find kids' fever-reducing medicines]( Makers of products like Children's Tylenol say they're trying to keep up with big demand as RSV, flu, and COVID spread. But medical experts note that kids' fevers don't always call for medicine. [Read more.]( [In the hunt for a male contraceptive, scientists look to stop sperm in their tracks]( For decades birth control research focused on women. Now there's a new push to develop gels, pills or other products that could keep men from getting their partners pregnant. [Read more.]( [In the hunt for a male contraceptive, scientists look to stop sperm in their tracks]( For decades birth control research focused on women. Now there's a new push to develop gels, pills or other products that could keep men from getting their partners pregnant. [Read more.]( [In second year of COVID, study finds fewer deaths but more years of life lost]( In 2021, 21% fewer people died of COVID than in 2020. But there were 500,000 more years of life lost, researchers found. The reason is that more younger people were dying of COVID, so they were missing out on more potential years of life. [Read more.]( [In second year of COVID, study finds fewer deaths but more years of life lost]( In 2021, 21% fewer people died of COVID than in 2020. But there were 500,000 more years of life lost, researchers found. The reason is that more younger people were dying of COVID, so they were missing out on more potential years of life. [Read more.]( What We're Reading 📚 Lately, it seems like every time I chat with a retail pharmacist, I hear that they’re overworked, and the pharmacy is understaffed. With the pandemic and vaccinations, pharmacists have become an increasingly visible, crucial – and strained — part of the health care system. So, it was with interest that I read about a new system CVS is trying out. It allows pharmacists to process prescriptions remotely, at least in part. As Sharon Terlep [reported for The Wall Street Journal]( several hundred CVS pharmacists can already prepare prescriptions and verify pill counts remotely, sometimes from home. This follows [Walgreens’ pivot to prescription-filling robots](. There are still a number of serious questions about efforts to ease the work of burned-out pharmacists, and barriers including state regulations limiting remote pharmacy work. But it’s interesting to see how the industry is grappling with a dwindling number of pharmacists (according to Terlep, applicants for pharmacy school have dropped by more than a third from a decade ago) and a landscape in which many are being lured away by hospitals and other jobs. "We would like to create a menu of options for men similar to what women have" — Stephanie Page, of University of Washington, about [developing contraceptives for men]( ICYMI ['The onslaught just keeps coming': Hospitals scramble to respond to the surge in children sick with RSV]( A spike in cases of respiratory syncytial virus, or RSV, is straining hospitals across Massachusetts and forcing them to employ new strategies to cope with the wave of young patients. [Read more.]( ['The onslaught just keeps coming': Hospitals scramble to respond to the surge in children sick with RSV]( A spike in cases of respiratory syncytial virus, or RSV, is straining hospitals across Massachusetts and forcing them to employ new strategies to cope with the wave of young patients. [Read more.]( 🧠💥 Did you know...💥🧠 ...[ants drink a milk-like fluid]( from other ants in their colony? It's a bit like mammals feeding milk to their young, according to The New York Times. The list of animals that get some type of milk-y liquid from a family member includes other surprises, too — like pigeons, spiders and beetles. 😎 Forward to a friend. They can sign up [here](. 📣 Give us your feedback: newsletters@wbur.org 📧 Get more WBUR stories sent to your inbox. [Check out all of our newsletter offerings.]( Support the news     Want to change how you receive these emails? Stop getting this newsletter by [updating your preferences.](  I don't want to hear from WBUR anymore. Unsubscribe from all WBUR editorial newsletters [here.](  Interested in learning more about corporate sponsorship? [Click here.]( Copyright © 2022 WBUR-FM, All rights reserved.

Marketing emails from wbur.org

View More
Sent On

07/06/2024

Sent On

06/06/2024

Sent On

05/06/2024

Sent On

04/06/2024

Sent On

04/06/2024

Sent On

03/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.